Behavioural Therapy vs. Medication: Which Approach Is Right for You?

Published on: September 27, 2023

Table of Contents

Behavioural Therapy vs. Medication: Which Approach Is Right for You?


Mental health has become a paramount concern in today’s rapidly evolving world, influencing millions globally[1]. Two of the most prevalent interventions for addressing mental health issues are behavioural therapy and medication, each with unique principles and practices. Behavioural therapy seeks to identify and modify detrimental patterns of thinking and behaviour, with popular methods including Cognitive Behavioral Therapy (CBT) and Dialectical Behavior Therapy (DBT)[2]. On the other hand, psychiatric medications, ranging from antidepressants to mood stabilisers, target the biological aspects of mental health, aiming to correct imbalances and alleviate symptoms[3].

Choosing between these approaches, or even integrating both, is profoundly personal. It’s influenced by the type and severity of the mental health concern, individual preferences, cultural factors, and even past treatment experiences[4]. While behavioural therapy equips individuals with long-term coping mechanisms, medication can offer swift symptom relief for many[2][3]. 

This article delves deeper into the intricacies of both approaches, providing a comprehensive analysis to aid you in making an informed decision. As mental health treatment becomes increasingly personalised, it’s vital to be equipped with knowledge, ensuring that the chosen path aligns with one’s unique needs and circumstances[5].

Understanding Behavioural Therapy

Behavioural therapy, grounded in behavioural and cognitive sciences principles, is a therapeutic approach that seeks to address and modify harmful patterns of thinking and behavioural treatments. It prioritises comprehensive present-day issues and tangible strategies for improving well-being[6].

Definition and Types

Behavioural therapy can be subdivided into several types, each tailored to address specific behavioural and cognitive challenges:

  • Cognitive Behavioral Therapy (CBT): Focused on identifying and correcting distorted thinking patterns, CBT is one of the most widely practised therapeutic modalities. It operates on the belief that thoughts influence feelings, which influence behaviours[7].
  • Dialectical Behavior Therapy (DBT): An offshoot of CBT, DBT is specifically designed for individuals with severe emotional dysregulation. It combines standard cognitive-behavioural techniques with mindfulness strategies, emphasising acceptance and change[8].
  • Exposure Therapy: Particularly effective for anxiety and phobia-related disorders, exposure therapy involves systematically and gradually exposing individuals to feared stimuli to reduce avoidance and distress[9].

How it Works

Behavioural therapy’s core is the notion that our adaptive and maladaptive behaviours are learned. By identifying negative patterns of thinking and behaviour, therapists help patients challenge and replace these patterns with more beneficial ones. The process often involves self-monitoring, skill development, and role-playing to ensure individuals can transfer their learnings into everyday situations. Over time, these new behaviours and thought patterns become ingrained with consistency and practice, offering long-lasting relief and improved well-being[10].


Delving into Medication

Medication remains a vital cornerstone in the treatment landscape of many mental health disorders. By targeting specific neurochemical imbalances or pathways, these pharmaceutical interventions can offer relief from symptoms and improve daily functioning for countless individuals[11].

Definition and Common Types

The realm of psychiatric medication is expansive, with drugs tailored to a spectrum of disorders:

  • Antidepressants: Primarily used for depression and anxiety disorders, these medications work by altering neurotransmitters in the brain, such as serotonin, norepinephrine, and dopamine[12].
  • Anxiolytics: Designed to relieve anxiety symptoms, these medications, including the commonly known benzodiazepines, work by depressing the central nervous system, promoting feelings of calm and relaxation[13].
  • Mood stabilisers: Used primarily in bipolar disorder, these medications help prevent the extreme highs and lows associated with the condition, ensuring a more balanced emotional state[14].

How it Works

Medications for mental health disorders operate by interacting with the body’s neurochemical mechanisms. Depending on the drug and its target, they can increase, decrease, or modify the activity of neurotransmitters, thereby influencing mood, thought processes, and overall behaviour. For instance, antidepressants like SSRIs (Selective Serotonin Reuptake Inhibitors) increase the availability of serotonin in the brain, a neurotransmitter often associated with feelings of well-being and happiness[15]. It’s essential to understand that while these medications can offer symptom relief, they may not address the underlying causes of the disorder. As such, a holistic approach combining medication with therapy is often recommended for sustained well-being.

Comparative Analysis

Choosing between behavioural therapy and medication is not binary; it often hinges on understanding each modality’s relative strengths and limitations. Both treatments offer valuable benefits but also have unique challenges, necessitating a comparative perspective to guide individuals towards an informed decision[16].

Efficacy Rates

While behavioural therapy and medication demonstrate significant efficacy in managing mental health disorders, their success rates can vary based on the condition being treated. For instance, CBT is particularly effective in treating anxiety disorders, often with outcomes comparable to or surpassing medication[17]. However, for severe mood disorders like bipolar disorder, a combination of medication and therapy tends to yield the best results[18].

Treatment Duration

Regarding the onset of relief, medications typically provide quicker symptom alleviation than therapy. Antidepressants, for example, can start showing effects within a few weeks, while the benefits of therapy might unfold over a more extended period as individuals process and internalise new coping mechanisms[19]. However, the sustainable benefits of therapy, particularly in preventing relapse and imparting life skills, can often endure beyond the treatment duration, unlike medication, which may require ongoing intake[20].

Cost implications

The financial aspects of treatment are also crucial. While medication might seem more cost-effective in the short term, especially with the availability of generic drugs, therapy, albeit pricier upfront, can offer long-term savings by reducing the need for continuous treatment and preventing potential relapses[20].

Factors to Consider When Choosing

Selecting the most fitting mental health treatment is deeply personal, rooted in individual preferences, specific conditions, and past experiences. It’s essential to recognise that there’s no “one-size-fits-all” solution, and the ideal approach often requires a combination of various modalities[21].

Severity and type of mental health issue

The nature and severity of the mental health disorder play a pivotal role in determining the best treatment approach. While mild to moderate depression might respond well to therapy alone, severe cases, especially those with suicidal ideation, may necessitate a combined approach of medication and therapy[22].

Personal preferences and comfort levels

Each individual’s comfort level with a treatment modality is paramount. Some may feel wary of the potential side effects of medication or have had negative experiences with certain drugs in the past. Conversely, others might feel hesitant about opening up in a therapeutic setting and prefer the privacy of a medication-based approach[23].

Existing health conditions

Physical health can influence the choice between therapy and medication. Some medications might interact negatively with drugs prescribed for other conditions or exacerbate specific physical ailments. Thus, a comprehensive health assessment is crucial before starting any psychiatric medication[24].

Past treatment experiences

Previous encounters with treatments can shape current decisions. For instance, individuals who’ve found relief with a particular medication might continue that route. At the same time, those with past success in therapy might gravitate towards a similar approach in managing recurrent issues[25].


Navigating the intricate landscape of mental health treatment options can be daunting. Both behavioural therapy and medication have proven efficacious in addressing various psychiatric conditions, yet their appropriateness hinges on individual nuances, specific disorders, and personal histories[5]. It’s paramount to understand that neither approach is universally superior; instead, their effectiveness often intertwines with personal preferences, the nature of the condition, and existing health parameters[26]. Encouragingly, combining both methods can amplify therapeutic outcomes, crafting a holistic healing journey for many[27]. Above all, seeking counsel from knowledgeable healthcare providers remains the cornerstone of making informed decisions[28]. As we usher in an era with increasing mental health awareness, the emphasis on personalised, patient-centric care has never been more pronounced, reminding us that the journey towards well-being is as unique as each individual[29].


  1. World Health Organization. (2020). Mental health: strengthening our response. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/mental-health-strengthening-our-response
  2. Hofmann, S. G., Asnaani, A., Vonk, I. J., Sawyer, A. T., & Fang, A. (2012). The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses. *Cognitive therapy and research*, 36(5), 427-440.
  3. National Institute of Mental Health. (2018). Mental Health Medications. U.S. Department of Health and Human Services. https://www.nimh.nih.gov/
  4. Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. *Archives of general psychiatry*, 62(6), 593-602.
  5. Johnsen, T. J., & Friborg, O. (2015). The effects of cognitive behavioural therapy as an anti-depressive treatment are falling: A meta-analysis. *Psychological bulletin*, 141(4), 747.
  6. Beck, A. T. (1979). Cognitive therapy and emotional disorders. Meridian. https://www.scirp.org/(S(i43dyn45teexjx455qlt3d2q))/reference/ReferencesPapers.aspx?ReferenceID=204916
  7. Dobson, D., & Dobson, K. S. (2018). Evidence-based practice of cognitive-behavioural therapy. Guilford Publications.
  8. Linehan, M. M. (2014). DBT Skills Training Manual. Guilford Publications.
  9. Craske, M. G., & Barlow, D. H. (2007). Mastery of your anxiety and panic: Therapist guide. Oxford University Press.
  10. Hayes, S. C., Strosahl, K. D., & Wilson, K. G. (2011). Acceptance and commitment therapy: The process and practice of mindful change. Guilford Press. https://www.guilford.com/books/Acceptance-and-Commitment-Therapy/Hayes-Strosahl-Wilson/9781462528943
  11. Hyman, S. E., & Nestler, E. J. (1996). Initiation and adaptation: A paradigm for understanding psychotropic drug action. *The American Journal of Psychiatry*, 153(2), 151-162.
  12. Stahl, S. M. (2013). *Stahl’s essential psychopharmacology: neuroscientific basis and practical applications*. Cambridge University Press.
  13. Baldwin, D., & Polkinghorn, C. (2005). Evidence-based pharmacotherapy of generalised anxiety disorder. *International Journal of Neuropsychopharmacology*, 8(2), 293-302.
  14. Goodwin, G. M. (2009). Evidence-based guidelines for treating bipolar disorder: Revised second edition—recommendations from the British Association for Psychopharmacology. *Journal of Psychopharmacology*, 23(4), 346-388.
  15. Frazer, A., & Benmansour, S. (2002). Delayed pharmacological effects of antidepressants. *Molecular psychiatry*, 7(1s), S23-S28.
  16. McHugh, R. K., Whitton, S. W., Peckham, A. D., Welge, J. A., & Otto, M. W. (2013). Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review. *The Journal of Clinical Psychiatry*, 74(6), 595. https://pubmed.ncbi.nlm.nih.gov/23842011/
  17. Hofmann, S. G., & Smits, J. A. J. (2008). Cognitive-behavioural therapy for adult anxiety disorders: a meta-analysis of randomised placebo-controlled trials. *The Journal of clinical psychiatry*, 69(4), 621-632.
  18. Miklowitz, D. J., & Porta, G. (2012). Family-focused treatment for adolescents with bipolar disorder. *Child and adolescent psychiatric clinics*, 21(3), 457-468.
  19. Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., … & Fava, M. (2006). Evaluating outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. *The American journal of psychiatry*, 163(1), 28-40.
  20. Cuijpers, P., Karyotaki, E., Weitz, E., Andersson, G., Hollon, S. D., & van Straten, A. (2017). The effects of psychotherapies for major depression in adults on remission, recovery, and improvement: a meta-analysis. *Journal of affective disorders*, 202, 511-517.
  21. Swift, J. K., & Callahan, J. L. (2009). The impact of client treatment preferences on outcome: a meta-analysis. *Journal of Clinical Psychology*, 65(4), 368-381.
  22. Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008). Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. *PLoS medicine*, 5(2), e45.
  23. McHugh, R. K., & Barlow, D. H. (2010). The dissemination and implementation of evidence-based psychological treatments: A review of current efforts. *American Psychologist*, 65(2), 73.
  24. Meyer, J. H., & Quilty, L. C. (2019). Individualising psychiatric treatment choices to ensure medication efficacy. *Depression and Anxiety*, 36(2), 97-108.
  25. Marcus, D. K., O’Connell, D., Norris, A. L., & Sawaqdeh, A. (2014). Is the Dodo bird endangered in the 21st century? A meta-analysis of treatment comparison studies. *Clinical Psychology Review*, 34(7), 519-530.
  26. Cuijpers, P., Sijbrandij, M., Koole, S. L., Andersson, G., Beekman, A. T., & Reynolds, C. F. (2013). Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis. *World Psychiatry*, 12(1), 56-62.
  27. Kocsis, J. H. (2016). Combination and augmentation strategies in depression: Review of efficacy and safety. *Annual Review of Medicine*, 67, 237-253.
  28. Leichsenring, F., & Steinert, C. (2017). Is cognitive behavioural therapy the gold standard for psychotherapy? The need for plurality in treatment and research. *JAMA*, 318(14), 1323-1324.
  29. Lambert, M. J., & Barley, D. E. (2002). Research summary on the therapeutic relationship and psychotherapy outcome. *Psychotherapy: Theory, Research, Practice, Training*, 38(4), 357-361.

Related News